OVERVIEW OF CARDIOVASCULAR PHYSIOLOGIC AND PHARMACOLOGIC ASPECTS OF SELECTIVE PHOSPHODIESTERASE PEAK-III INHIBITORS

被引:38
作者
EVANS, DB
机构
关键词
D O I
10.1016/0002-9149(89)90385-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:A9 / A11
页数:3
相关论文
共 34 条
[1]  
ALOUSI A, 1980, FED PROC, V39, P855
[2]   CHARACTERIZATION OF THE CARDIOTONIC EFFECTS OF MILRINONE, A NEW AND POTENT CARDIAC BIPYRIDINE, ON ISOLATED-TISSUES FROM SEVERAL ANIMAL SPECIES [J].
ALOUSI, AA ;
STANKUS, GP ;
STUART, JC ;
WALTON, LH .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1983, 5 (05) :804-811
[3]  
BRAUNWALD E, 1984, INVESTIGATION NEW IN, P1
[4]  
CODY RJ, 1984, CLIN RES, V32, pA443
[5]   CARDIOVASCULAR PROPERTIES OF A NEW CARDIOTONIC AGENT - MDL 17,043 (1,3-DIHYDRO-4-METHYL-5-[4-(METHYLTHIO)-BENZOYL]-2H-IMIDAZOL-2-ONE) [J].
DAGE, RC ;
ROEBEL, LE ;
HSIEH, CP ;
WEINER, DL ;
WOODWARD, JK .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1982, 4 (03) :500-508
[6]  
DAGE RC, 1986, NEW CARDIOVASCULAR D, P63
[7]  
DEFELICE AF, 1987, FASEB J, V46, P373
[8]  
DEFEO TT, 1985, CIRCULATION S3, V72, pA312
[9]   MODULATION OF CAMP - MECHANISM FOR POSITIVE INOTROPIC ACTION [J].
EVANS, DB .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1986, 8 :S22-S29
[10]   CARDIOVASCULAR PHARMACOLOGY OF THE CARDIOTONIC, IMAZODAN (CL-914) [J].
EVANS, DB ;
POTOCZAK, RE ;
STEFFEN, RP ;
BURMEISTER, WE ;
MCNISH, RW ;
SCHENDEN, JA ;
KAPLAN, HR .
DRUG DEVELOPMENT RESEARCH, 1986, 9 (02) :143-157